Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSX: $WEED.TO,
CSE: $CHOO,C, CSE: $CRZ.C, TSX: $VFF.TO, TSXV: $EMH.V, CSE: $HUGE.C
Delta, Kelowna, BC –August 23, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/08231Potcasts-TSX-WEED-CSE-CHOO-CRZ-VFF-EMH-HUGE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Choom™ (CSE:
CHOO & OTCQB:CHOOF), CannaRoyalty Corp.(CSE: CRZ) , Village Farms International,
Inc. (TSX: VFF and OTC: VFFIF), Emerald Health Therapeutics,
Inc. ( TSX-Venture: EMH) , Canopy Growth
Corporation (TSX: WEED and NYSE:CGC ) and FSD Pharma Inc. (CSE: HUGE and OTC: FSDDF).
Choom™ an emerging, fully-integrated cannabis company,
announced that it has advanced its retail portfolio and the build-out of its
cannabis retail store network in Alberta and British Columbia.
Choom has secured the rights to an additional 5 retail locations in
Alberta and 7 in B.C. These new retail opportunities bring Choom's total retail
potential up to 52 locations across western Canada. Choom's rapidly expanding
provincial presence now stands at 29 leases in highly strategic and secure
locations in Alberta with 28 applications submitted, in combination with 17
retail opportunities in B.C.
CannaRoyalty Corp. today announced the
Company's financial results for the three and six-month periods ended June 30,
2018.
"Q2 marked a turning point for CannaRoyalty and its shareholders as
the team translated strategy and execution into record financial performance.
The Company generated earnings per share of $0.18 primarily by delivering on
its stated objective of rationalizing early passive investments. The Company
also generated a record adjusted EBITDA result for a Canadian-listed cannabis
company2," said Marc Lustig, CEO of CannaRoyalty. "Q2 is
the beginning of a multi-quarter parabolic step change in revenue, powered by
sequential acquisitions and organic growth. CannaRoyalty generated a record
$3.5 million in revenue this quarter, a 446% increase from Q1 and more than the
Company generated in all of 2017. These results reflect the successful
initiation of the Company's strategic focus on building its Californian
distribution and brands platform. This growth is expected to continue in Q3 and
Q4 as FloraCal and RVR are added to the Company's financials and as our team
continues to grow market share and expand the Company's supporting
manufacturing and value-add services footprint. Both RVR and FloraCal are
performing above expectations, and we are actively executing our plans to
increase the revenue generating capacity of both companies. I thank all of our
long term shareholders for their faith in this team and our plan. I am proud to
say that this is truly just the beginning of the CannaRoyalty story."
Some of the financial results highlights included:
·
Q2-2018 Revenue of $3.5
million compared to $643,437 in Q1-2018 – marks the successful initiation of
California distribution and manufacturing strategy.
·
Net income of $9.3 million
(EPS of $0.18) and EBITDA of $10.4 million generated through execution of
stated strategy to rationalize non-core assets and an increase in gross margin
related to growing product sales.
·
FloraCal (closed July 2nd)
and RVR Distribution ("RVR") (closing in Q3-2018) are performing
above plan and are expected to drive sequential revenue growth through the
second half of 2018 and beyond.
·
Premier cannabis brand
development platform powered by five licensed distribution and manufacturing
facilities across California, delivering several of the state's top independent
branded products to the majority of licensed dispensaries in the state.17
Village Farms International, Inc. and Emerald Health Therapeutics,
Inctoday announced that their 50/50 joint venture for large-scale, low-cost,
high-quality cannabis production, Pure Sunfarms, received from Health Canada
its third amendment to the cultivation license for its Delta 3 greenhouse in
Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis
production area by 195,000 square feet to approximately 420,000 square feet of
the 1.1-million square foot Delta 3 production facility. The newly licensed
area will be in commercial production this week, as the Delta 3 nursery has
been producing cuttings in anticipation of this expansion.
Pure Sunfarms expects to have the full 1.1 million square foot Delta 3
facility, one of the single largest cannabis growing facilities in the world,
converted for cannabis production by year end. The technologically-advanced
Delta 3 greenhouse design is based on decades of large-scale, low-cost
agricultural production experience and extensive cannabis expertise, resulting
in a state-of-the-art facility with 17 grow rooms (seven of which are now
licensed) optimized for year-round harvesting (more than 85 harvests annually)
and an automated process line encompassing harvesting, trimming, drying and
packaging.
Canopy Rivers Corporation, the venture capital investment platform of
Canopy Growth Corporation, announced that it has set a date of September 12,
2018, for its upcoming shareholder meeting in connection with the proposed
business combination involving AIM2 Ventures Inc. and Canopy Rivers.
As previously announced, Canopy Rivers has entered into a definitive
amalgamation agreement with AIM2, which outlines the terms and conditions
pursuant to which the parties will complete the Go Public Transaction. The Go
Public Transaction will result in a reverse take-over of AIM2 by Canopy Rivers
and will constitute AIM2's "Qualifying Transaction" under Policy 2.4
– Capital Pool Companies of the
TSXV Corporate Finance Manual.
Subject to receipt of all required approvals, including the final
approval of the TSX Venture Exchange, the Go Public Transaction is expected to
close and the subordinated voting shares of the resulting issuer are expected
to commence trading on the TSXV under the symbol "RIV" during the
week of September 17, 2018.
FSD Pharma Inc. reported today that its strategic R&D partner,
SciCann Therapeutics Inc., has achieved positive results in a pre-clinical
efficacy study of its proprietary "Steady Stomach" CBD combination
product for Inflammatory Bowel Disease (IBD). Under the terms of the agreement
between FSD and SciCann, FSD Pharma holds exclusive marketing and distribution
rights for the "Steady Stomach" product in Canada.
The "Steady Stomach" product is a patent-pending combination
of Cannabidiol (CBD) together with additional synergistic factors that potentiate
and activate the anti-inflammatory properties of CBD, thus making it more
effective as a potential treatment for IBD disorders. All active ingredients of
the "Steady Stomach" formulation are natural food-grade compounds,
thus qualifying it as a CBD food supplement product. Previously completed tox
studies in rodents performed by SciCann has demonstrated very high safety
profile for the combination product, without any observed adverse events.
The pre-clinical study used a gold standard rodent model of Ulcerative
Colitis, and demonstrated a significant 3-fold improved efficacy for the
combination product, as compared to CBD alone, in reversing the deleterious
effects caused by the colitis induction agent in the study model. Specifically,
while the CBD alone arm achieved only a 27% improvement score as compared to
the non-treated control arm, the "Steady Stomach" combination
treatment arm achieved a 79% improvement score, thus almost completely
alleviating the Colitis symptoms induced in the model animals.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
No comments:
Post a Comment